Journal of Pharmacological Sciences · 2012 · 70 citations · 12 references
PharmacyNeurobiologyNeuroscienceDevelopmental NeurobiologyDevelopmental NeuroscienceDevelopmental ToxicologyDevelopmental NeurotoxicityFetal PhysiologyPregnancyPrenatal DevelopmentPrenatal ToxicityPrenatal ToxicologyNeurodevelopmental Outcomes After Prenatal ExposurePharmaceutical Exposure During PregnancyPrenatal Drug ExposurePrenatal NeuropharmacologyPrenatal Substance ExposureRodent Brain DevelopmentValproic Acid
We have recently shown that prenatal valproic acid (VPA) exposure causes autism spectrum disorders-like behavioral abnormalities and Nissl-positive cell loss in both prefrontal and somatosensory cortices in male mice. We have also found that VPA-induced social interaction deficits are observed in male but not female offspring. This study demonstrated that the exposure to VPA at embryonic day 12.5 significantly decreased Nissl-positive cell numbers in the prefrontal cortex, but not in the somatosensory cortex, in female offspring. These findings suggest that VPA-induced morphological abnormalities in the somatosensory cortex may be involved in the sex-dependent social interaction deficits.
12
Fetal valproate syndrome and autism: additional evidence of an association
Gail Williams, John King, Michael L. Cunningham et al. · Developmental Medicine & Child Neurology · 2001 · 283 citations · Full text
Medicine, Genetics, Pediatrics +11